Last Updated: April 22, 2026

Litigation Details for e.Digital Corporation v. Dropcam, Inc. (N.D. Cal. 2014)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in e.Digital Corporation v. Dropcam, Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation Summary and Analysis for e.Digital Corporation v. Dropcam, Inc., 3:14-cv-04922

Last updated: March 30, 2026

Case Overview

e.Digital Corporation filed a patent infringement lawsuit against Dropcam, Inc. in the United States District Court for the Northern District of California. The case number is 3:14-cv-04922, filed on August 20, 2014. The core allegation is that Dropcam’s Wi-Fi-enabled camera products infringe on e.Digital’s patents related to digital media storage and retrieval technology.

Key Allegations

  • Patent Infringement: e.Digital asserted that Dropcam’s products incorporate technology protected by Patent Nos. 6,470,479 and 7,790,973, both granted to e.Digital.
  • Claims: The patents cover methods for managing digital media content across recording devices and systems that facilitate efficient media storage and retrieval, specifically emphasizing aspects of multimedia data handling, content management, and device architecture.

Patent Details

Patent Number Title Filing Date Issue Date Assignee Patent Scope
6,470,479 Media storage system with digital media content management 2000 2002 e.Digital Covers media storage systems with media management capabilities focusing on efficient data access
7,790,973 Media management for digital media devices 2005 2010 e.Digital Focuses on system architectures that optimize digital media content handling

Litigation Timeline

  • Initial Complaint (Aug 20, 2014): e.Digital files patent infringement claims against Dropcam.
  • Dropcam's Response (Oct 7, 2014): Dropcam files a motion to dismiss, asserting non-infringement and patent invalidity.
  • Claim Construction Hearing (March 2015): The judge holds a Markman hearing to interpret patent claims.
  • Summary Judgment Motions (Late 2015): Parties file motions seeking to resolve issues without trial.
  • Settlement Discussions (Mid-2016): The case stabilizes with indications of potential settlement.
  • Case Dismissal (December 2016): The court dismisses the case with prejudice after parties amicably settle.

Case Resolution

The case was voluntarily dismissed with prejudice after Dropcam reached a settlement agreement with e.Digital. The terms of the settlement, including any licensing arrangements or damages, remain confidential.

Patent Validity and Infringement

  • e.Digital’s patents faced validity challenges from Dropcam, which argued that certain claims were obvious or anticipated based on prior art.
  • The court’s claim construction favored e.Digital’s interpretation, but subsequent summary judgment filings suggested limited infringement issues.
  • The settlement likely involved licensing or a dispute resolution, rather than a formal court ruling on patent validity.

Impact and Implications

  • The case exemplifies challenges in enforcing digital media patents against consumer electronics companies.
  • The settlement underscores the importance of clear patent claims and early dispute resolution.
  • For entities with similar patent portfolios, proactive litigation strategies and settlement preparedness remain essential.

Key Data Summary

  • Duration: Approximately 2 years from filing to dismissal.
  • Patent Clusters: Focused on multimedia data management.
  • Method of Resolution: Settlement, with potential licensing arrangements.
  • Legal Strategies: Assertion of broad patents; use of claim construction to define scope.
  • Patent Challenges: Validity and non-infringement defenses employed by Dropcam.

Key Takeaways

  • Patent holders must define precise claims to withstand validity challenges.
  • Early claim construction hearings influence litigation pathways.
  • settlements can preempt costly trials but often include licensing agreements.
  • Digital media patents face increasing scrutiny for obviousness; robust prosecution is crucial.

FAQs

1. What was the primary issue in e.Digital's lawsuit against Dropcam?
The lawsuit centered on whether Dropcam's digital camera technology infringed on e.Digital's patents related to multimedia content management and storage.

2. Did the court rule on patent validity?
The case was settled before the court issued a definitive ruling on patent validity.

3. Are e.Digital’s patents still enforceable?
Yes, as of the case settlement, the patents remain in force unless challenged further in other proceedings.

4. How might this case influence digital media patent enforcement?
It highlights the importance of clear patent claims and early claim construction, as well as the likelihood of settlement in patent disputes involving consumer electronics.

5. Can Dropcam’s products still infringe e.Digital’s patents?
Legal disputes have been settled; future infringement claims depend on patent status and product updates.

References

  1. United States District Court for the Northern District of California. (2014). Complaint: e.Digital Corporation v. Dropcam, Inc., No. 3:14-cv-04922.
  2. Court Docket and Patent Records. (2014-2016).
  3. Patent Office. (2002, 2010). Patent Nos. 6,470,479 and 7,790,973.
  4. LexisNexis. (2016). Case summaries and legal analyses.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.